論文 - 詳細
| RRC ID | 41861 |
|---|---|
| 著者 | Ebert MP, Yu J, Hoffmann J, Rocco A, Röcken C, Kahmann S, Müller O, Korc M, Sung JJ, Malfertheiner P. |
| タイトル | Loss of beta-catenin expression in metastatic gastric cancer. |
| ジャーナル | J Clin Oncol |
| Abstract |
PURPOSE:Beta-catenin (beta-catenin) participates in intercellular adhesion and is an integral part of the Wnt signaling pathway. The role of beta-catenin in the pathogenesis of gastric cancer and its metastasis is largely unknown. PATIENTS AND METHODS:Immunohistochemistry and Western blot analysis were used to analyze the expression of beta-catenin in 87 human gastric cancers, in metastasis and cancer cell lines. The beta-catenin and the adenomatous polyposis coli (APC) genes were analyzed for gene mutations. Furthermore, methylation of the beta-catenin promoter in cell lines was assessed by treatment with 5'-azadeoxycytidine and sodium bisulfite genomic sequencing. RESULTS:beta-Catenin expression was present at either the cell membrane or the cytoplasm in 34 of 75 primary gastric cancers. Expression of beta-catenin was significantly more frequent in intestinal-type (P =.0049) and well-differentiated gastric cancers (P <.001). There were no quantitative differences between gastric cancers and the nonmalignant gastric tissues, as determined by Western blot analysis. One of 18 metastatic cancer lesions and four of five gastric cancer cell lines expressed beta-catenin protein. N87 cells, derived from the liver metastasis of a gastric cancer, did not express beta-catenin. Treatment with 5'-azadeoxycytidine restored beta-catenin protein levels in this cell line, which exhibited significantly more 5-methylcytosines in the beta-catenin promoter compared with the other cell lines. CONCLUSION:beta-Catenin expression is lost in a subgroup of primary gastric cancers, is frequently absent in metastases, and exhibits nuclear localization in cancers with either beta-catenin or APC gene mutations. Interestingly, the loss of beta-catenin expression in metastatic gastric cancers may result from hypermethylation of the beta-catenin promoter. |
| 巻・号 | 21(9) |
| ページ | 1708-14 |
| 公開日 | 2003-5-1 |
| DOI | 10.1200/JCO.2003.10.017 |
| PII | JCO.2003.10.017 |
| PMID | 12721245 |
| MeSH | Adenomatous Polyposis Coli / genetics* Adult Aged Blotting, Western Cadherins Cell Membrane Cytoplasm Cytoskeletal Proteins / biosynthesis* Cytoskeletal Proteins / genetics DNA Methylation Female Gene Expression Regulation, Neoplastic* Genes, APC* Humans Immunohistochemistry Male Middle Aged Neoplasm Metastasis / genetics* Promoter Regions, Genetic Stomach Neoplasms / genetics* Stomach Neoplasms / pathology* Trans-Activators / biosynthesis* Trans-Activators / genetics Tumor Cells, Cultured beta Catenin |
| IF | 32.956 |
| 引用数 | 76 |
| WOS 分野 | ONCOLOGY |
| リソース情報 | |
| ヒト・動物細胞 | |